Reslizumab 25mg/2.5ml solution for infusion vials
- SNOMED code
34812511000001102- Active compound
- Reslizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 2.5 ml, vial
- Ingredients
- Reslizumab
— 10 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd)
in short Cinqaero 25mg/2.5ml concentrate for inf vials
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials
- SNOMED code
34808911000001109- Supplier
- Teva UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial34809111000001104 ref. pack | 💯 Available Legal category: POM | 5017007020554End: 5017007604495 | NHS Indicative Price £124.99 | • Personally Administered • Hospital |
| — |
Reference packs
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial
- SNOMED code
34808811000001104- Quantity and unit
- 1 vial
- Packs